Attention Deficit Hyperactivity Disorder
Influence of tomoxetine hydrochloride on the cognitive processing of children with attention deficit hyperactivity disorder
Wang Dan, Qin Ling, Liu Hairun, Li Dandan, Yao Chunling, Fu Yanhong, Zhang Hong, Huang Siyan
Published 2022-09-20
Cite as Chin J Behav Med & Brain Sci, 2022, 31(9): 819-825. DOI: 10.3760/cma.j.cn371468-20211124-00682
Abstract
ObjectiveTo explore the influence of tomoxetine hydrochloride on the cognitive processing of children with attention deficit hyperactivity disorder (ADHD).
MethodsFrom January 2018 to July 2021, 62 ADHD children who were treated with tomoxetine hydrochloride for the first time for(8±4) weeks were selected as the ADHD group.And 62 healthy children matched with age and sex were selected as the healthy control group.Pre-test and post-test by the Das-Naglieri: Cognitive Assessment System(DN: CAS) were performed to evaluate the cognitive function of all individuals.The differences of cognitive processing in pre-treatment and post-treatment of ADHD group were compared with those in healthy control group.The difference between before and after treatment of ADHD group was also compared.SPSS 26.0 statistical software was adopted for statistical analysis.The scores of ADHD group pre-treatment and post-treatment were compared by paired sample t-test, and the scores of ADHD group pre-treatment and post-treatment were compared with those of healthy control group by independent sample t-test.
ResultsCompared with healthy control group, there were lower of planning score((18.77±5.92) vs (28.56±5.55)), attention score((22.24±5.93) vs (29.56±6.16)), simultaneous processing ((34.21±7.75) vs (37.61±6.29)), successive processing((30.37±7.12) vs (33.74±5.43)), and the total scores((105.60±21.29) vs (134.84±22.87)) in ADHD group before treatment, and there were significant differences(t=9.49, 6.74, 2.68, 2.96, 7.36, all P<0.05). Compared with healthy control group, there were lower of planning score ((22.13±5.99)s), attention score((25.26±7.11) with significant difference(t=6.20, 3.60, both P<0.05) in ADHD group after treatment.And there was no significant difference in the simultaneous processing test and the successive processing test after treatment compared with the healthy control group(both P>0.05). In ADHD group, the scores of planning, simultaneous processing, attention, successive processing and the total score were significantly higher after treatment than those before treatment and there were significant differences(t=-6.03, -4.13, -4.77, -5.48, -8.59, all P<0.05). (2) Compared with the healthy control group, there were lower of matching number score and other 8 sub-test scales in DN: CAS test in ADHD group before treatment, and the differences were statistically significant (all P<0.05). Meanwhile, there were still lower of matching number score and other 4 sub-test scales in DN: CAS test in ADHD group after treatment, and the differences were statistically significant (all P<0.05). The matching number score and other 10 sub-test scales in DN: CAS test in ADHD group after treatment were all higher than those of before treatment(all P<0.05).
ConclusionThe planning, attention, simultaneous processing, successive processing and total cognitive function of ADHD children were significantly improved after treatment with tomoxetine hydrochloride, special for simultaneous processing and successive processing.
Key words:
Tomoxetine hydrochloride; Das-Naglieri cognitive assessment system; Attention deficit hyperactivity disorder; Cognitive processing
Contributor Information
Wang Dan
Center for Cognitive and Sleep, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
Qin Ling
Center for Cognitive and Sleep, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
Liu Hairun
Center for Cognitive and Sleep, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
Li Dandan
Center for Cognitive and Sleep, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
Yao Chunling
Center for Cognitive and Sleep, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
Fu Yanhong
Center for Cognitive and Sleep, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
Zhang Hong
Center for Cognitive and Sleep, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
Huang Siyan
Center for Cognitive and Sleep, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China